VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Therapeutic choices after hypomethylating agent resistance for myelodysplastic syndromes.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Therapeutic choices after hypomethylating agent resistance for myelodysplastic syndromes.
Therapeutic choices after hypomethylating agent resistance for myelodysplastic syndromes. Curr Opin Hematol. 2018 03; 25(2):146-153.
View in:
PubMed
subject areas
Antibodies, Monoclonal, Humanized
Azacitidine
Drug Resistance
Enzyme Inhibitors
Humans
Ipilimumab
Myelodysplastic Syndromes
authors with profiles
GUILLERMO GARCIA-MANERO
ELIAS JOSEPH JABBOUR